Literature DB >> 22266202

Risk factors for intubation-surfactant-extubation (INSURE) failure and multiple INSURE strategy in preterm infants.

Carlo Dani1, Iuri Corsini, Chiara Poggi.   

Abstract

The INSURE method, which consists of an intubation-surfactant-extubation sequence, is effective in reducing the need for mechanical ventilation (MV), the duration of respiratory support, and the need for surfactant replacement in preterm infants with respiratory distress syndrome. Although beneficial, the INSURE method fails to avoid MV in selected patients. We demonstrated that body weight <750 g, pO(2)/FiO(2) <218, and a/ApO(2) <0.44 at the first blood gas analysis are independent risk factors for INSURE failure in infants with gestational age <30 weeks. Moreover, we demonstrated that the INSURE treatment can be safely repeated with the aim to avoid MV, since the respiratory outcome did not differ between infants treated with single or multiple INSURE procedures. Copyright Â
© 2012. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266202     DOI: 10.1016/j.earlhumdev.2011.12.019

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  8 in total

1.  Intubation-Surfactant-Extubation Strategy in a Medical Resource-limited Department: A Prospective Study.

Authors:  Ons Azzabi; Ines Selmi; Hedia Bellali; Nadia Siala; Yosr Dridi; Ilhem Fetni; Mohamed Kouni Chahed; Sonia Halioui; Ahmed Maherzi
Journal:  J Trop Pediatr       Date:  2016-01-07       Impact factor: 1.165

Review 2.  Challenges in developing a consensus definition of neonatal sepsis.

Authors:  Matthew McGovern; Eric Giannoni; Helmut Kuester; Mark A Turner; Agnes van den Hoogen; Joseph M Bliss; Joyce M Koenig; Fleur M Keij; Jan Mazela; Rebecca Finnegan; Marina Degtyareva; Sinno H P Simons; Willem P de Boode; Tobias Strunk; Irwin K M Reiss; James L Wynn; Eleanor J Molloy
Journal:  Pediatr Res       Date:  2020-03-03       Impact factor: 3.756

Review 3.  Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.

Authors:  Nashwa El-Gendy; Anubhav Kaviratna; Cory Berkland; Prajnaparamita Dhar
Journal:  Ther Deliv       Date:  2013-08

4.  Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery.

Authors:  J M B Pinheiro; Q Santana-Rivas; C Pezzano
Journal:  J Perinatol       Date:  2015-12-03       Impact factor: 2.521

5.  Criteria for Using INSURE in Management of Premature Babies with Respiratory Distress Syndrome.

Authors:  Faten Awaysheh; Nisreen Alhmaiedeen; Raeda Al-Ghananim; Areej Bsharat; Mohammad Al-Hasan
Journal:  Med Arch       Date:  2019-08

6.  Flow-synchronized nasal intermittent positive pressure ventilation for infants <32 weeks' gestation with respiratory distress syndrome.

Authors:  C Gizzi; P Papoff; I Giordano; L Massenzi; C S Barbàra; M Campelli; V Panetta; R Agostino; C Moretti
Journal:  Crit Care Res Pract       Date:  2012-11-27

7.  Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants.

Authors:  Ji Won Koh; Jong-Wan Kim; Young Pyo Chang
Journal:  Korean J Pediatr       Date:  2018-09-16

8.  Examining Variations in Surfactant Administration (ENVISION): A Neonatology Insights Pilot Project.

Authors:  Priya Patel; Andrew Houck; Daniel Fuentes
Journal:  Children (Basel)       Date:  2021-03-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.